Pfizer completes acquisition of Metsera for USD 7 billion to expand obesity and cardiometabolic…
The deal adds multiple clinical-stage candidates, including GLP-1 and amylin assets, as Metsera becomes a wholly owned Pfizer…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Bry-Air launches P80x dehumidifier using MOF technology for the pharma industry
The P80x features MOF-based MIRACLE Next-Gen Rotor and heat pump compatibility for reduced energy use and lower regeneration…
Lupin launches Risperidone extended-release injectable suspension in the U.S. with 180-day CGT…
The launch marks Lupin’s first product using PrecisionSphereTM, the long-acting injectable platform developed by Nanomi B.V.
Zydus Lifesciences receives USFDA approval for Diroximel Fumarate delayed-release capsules
The approval covers the treatment of relapsing forms of multiple sclerosis in adults, with production to take place at Zydus…
Alembic receives USFDA approval for Dexlansoprazole delayed-release capsules
Alembic Pharmaceuticals secures final USFDA approval for Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg,…
Lupin achieves S&P Global ESG Score of 91 for 2025, surpassing pharma industry average
Lupin reports a 91-point S&P Global ESG Score for 2025, exceeding the pharma industry average of 28 and marking a major rise…
Lupin receives EIR from U.S. FDA for Aurangabad facility
The Establishment Inspection Report follows a product-specific Pre-Approval Inspection conducted by the U.S. FDA at Lupin’s…
THSTI, Miltenyi Biotec and BIRAC launch India’s first hands-on training on cell and gene therapy…
The initiative focuses on building India’s capacity in CAR-T cell therapy through practical training and industry-academia…
Lupin manufacturing solutions commissions dedicated oncology block at Vizag facility
Lupin Manufacturing Solutions has commissioned a new high-containment oncology unit at its Vizag site to expand contract…
Novo Nordisk India reduces Wegovy prices by 37% to expand access for people
Novo Nordisk India has reduced the weekly price of the starting dose of Wegovy from INR 4,336 to INR 2,712, aiming to make…